Establishment of a 7-ethyl-10-hydroxy-camptothecin-resistant small cell lung cancer cell line

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3911-3916

  Chikamori, Masakazu ^a   Takigawa, Nagio ^b   Kiura, Katsuyuki ^a,d   Tabata, Masahiro ^a   Shibayama, Takuo ^b   Segawa, Yoshihiko ^a   Ueoka, Hiroshi ^a,c   Ohnoshi, Taisuke ^a   Tanimoto, Mitsune ^a,c  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b National Hospital Organization   (Japan)

^c OKAYAMA UNIVERSITY   (Japan)

^d OKAYAMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Drug resistance; Irinotecan; Small cell lung cancer; Topoisomerase

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4 HYDROPEROXYCYCLOPHOSPHAMIDE; 4 HYDROPEROXYIFOSFAMIDE; 7 ETHYL 10 HYDROXYCAMPTOTHECIN; ALKYLATING AGENT; ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DNA TOPOISOMERASE INHIBITOR; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLIC ACID ANTAGONIST; GYRASE INHIBITOR; IFOSFAMIDE; IRINOTECAN; METHOTREXATE; MITOMYCIN C; NAVELBINE; PLATINUM; TOPOTECAN; VINCRISTINE; VINDESINE; 7-ETHYL-10-HYDROXYCAMPTOTHECIN; CAMPTOTHECIN; DRUG DERIVATIVE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CROSS RESISTANCE; CYTOTOXICITY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; DRUG RESISTANCE; DRUG SCREENING; LUNG TUMOR; MULTIDRUG RESISTANCE; PATHOLOGY; SMALL CELL CARCINOMA; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CARCINOMA, SMALL CELL; CELL LINE, TUMOR; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LUNG NEOPLASMS;

EID: 14944382966     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Johnson DH: Recent developments in chemotherapy treatment of small cell lung cancer. Semin Oncol 20: 315-325, 1993.
2. Doyle LA: Mechanisms of drug resistance in human lung cancer cells. Semin Oncol 20: 326-337, 1993.
3. Kunimoto T, Nitta K, Tanaka T, Kunimoto T, Nitta K, Tanaka T, Uehara N, Baba H, Takeuchi M, Yokokura T, Sawada S, Miyasaka T and Mutai M: Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors. Cancer Res 47: 5944-5947, 1987.
4. Hsiang YH and Liu LF: Identification of mammalian DNA topoisomerase I as an intracellular target of the anticancer drug camptothecin. Cancer Res 48: 1722-1726, 1988.
5. Masuda N, Fukuoka M, Kusunoki Y, Matsui K, Takifuji N, Kudoh S, Negoro S, Nishioka M, Nakagawa K and Takada M: CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer. J Clin Oncol 10: 1225-1229, 1992.
6. Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S and Saijo N: Japan Clinical Oncology Group: Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346: 85-91, 2002.
7. Miyamoto H: Establishment and characterization of an adriamycin-resistant subline of human small cell lung cancer cells. Acta Med Okayama 40: 65-73, 1986.
8. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Meth 65: 55-63, 1983.
9. Carmichael J, DeGraff WG, Gazdar AF, Minna JD and Mitchell JB: Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936-942, 1987.
10. Tietze F: Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 27: 502-522, 1969.
11. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
12. Tsutsui K, Tsutsui K, Sakurai H, Shohmori T and Oda T: Levels of topoisomerase II and DNA polymerase alpha are regulated independently in developing neuronal nuclei. Biochem Biophys Res Commun 138: 1116-1122, 1986.
13. Miller KG, Liu LF and Englund PT: A homogeneous type II DNA topoisomerase from HeLa cell nuclei. J Biol Chem 256: 9334-9339, 1981.
14. Andoh T, Ishii K, Suzuki Y, Ikegami Y, Kusunoki Y, Takemoto Y and Okada K: Characterization of a mammalian mutant with a camptothecin-resistant DNA topoisomerase I. Proc Natl Acad Sci USA 84: 5565-5569, 1987.
15. Eng WK, McCabe FL, Tan KB, Mattern MR, Hofmann GA, Woessner RD, Hertzberg RP and Johnson RK: Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase 1 content. Mol Pharmacol 38: 471-80, 1990.
16. Gupta RS, Gupta R, Eng B, Lock RB, Ross WE, Hertzberg RP, Caranfa MJ and Johnson RK: Camptothecin-resistant mutants of Chinese hamster ovary cells containing a resistant form of topoisomerase I. Cancer Res 48: 6404-6410, 1988.
17. Sugimoto Y, Tsukahara S, Oh-hara T, Isoe T and Tsuruo T: Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. Cancer Res 50: 6925-6930, 1990.
18. Sugimoto Y, Tsukahara S, Oh-hara T, Liu LF and Tsuruo T: Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. Cancer Res 50: 7962-7965, 1990.
19. Kanzawa F, Sugimoto Y, Minato K, Kasahara K, Bungo M, Nakagawa K, Fujiwara Y, Liu LF and Saijo N: Establishment of a camptothecin analogue (CPT-11)-resistant cell line of human non-small cell lung cancer: characterization and mechanism of resistance. Cancer Res 50: 5919-5924, 1990.
20. Joto N, Ishii M, Minami M, Kuga H, Mitsui I and Tohgo A: DX-8951f, a water-soluble camptothecin analog, exhibits potent antitumor activity against a human lung cancer cell line and its SN-38-resistant variant. Int J Cancer 72: 980-686, 1997.
21. Maliepaard M, van Gastelen MA, de Jong LA, Pluim D, van Waardenburg RC, Ruevekamp-Helmers MC, Floot BG and Schellens JH: Overexpression of the BCRP/MXR/ABCP gene in a topotecan-selected ovarian tumor cell line. Cancer Res 59: 4559-4563, 1999.
22. Garcia-Carbonero R and Supko JG: Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins. Clin Cancer Res 8: 641-661, 2002.
23. Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami Y, Sugahara K, Yamada Y, Kamihira S, Doyle LA, Ross DD and Kohno S: Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 280: 1216-1223, 2001.
24. Kozuki T, Katayama H, Tabata M, Hisamoto A, Fujiwara K, Hotta K, Takigawa N, Kiura K, Ueoka H and Tanimoto M: Expression of ABC transporters in drug resistant sub-lines established from one human small cell lung cancer cell line SBC-3. Proc Am Assoc Cancer Res 44: R3681, 2003.
25. Sugimoto Y, Tsukahara S, Oh-hara T, Liu LF and Tsuruo T: Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. Cancer Res 50: 7962-7965, 1990.
26. Woessner RD, Eng WK, Hofmann GA, Rieman DJ, McCabe FL, Hertzberg RP, Mattern MR, Tan KB and Johnson RK: Camptothecin hyper-resistant P388 cells: drug-dependent reduction in topoisomerase I content. Oncol Res 4: 481-488, 1992.
27. Goto S, Kamada K, Soh Y, Ihara Y and Kondo T: Significance of nuclear glutathione S-transferase pi in resistance to anti-cancer drugs. Jpn J Cancer Res 93: 1047-1056, 2002.
28. Moritaka T, Kiura K, Ueoka H, Tabata M, Segawa Y, Shibayama T, Takigawa N, Ohnoshi T and Harada M: Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids. Anticancer Res 18: 927-933, 1998.
29. Kiura K, Ohnoshi T, Tabata M, Shibayama T and Kimura I: Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance. Acta Med Okayama 47: 191-197, 1993.
30. Takigawa N, Ohnoshi T, Ueoka H, Kiura K and Kimura I: Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line. Acta Med Okayama 46: 203-212, 1992.
31. Jensen PB, Christensen IJ, Sehested M, Hansen HH and Vindelov L: Differential cytotoxity of 19 anticancer agents in wild type and etoposide resistant small cell lung cancer cell lines. Br J Cancer 67: 311-320, 1993.